HTLF Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
HTLF Bank's BMY Position: Q4 2024 in Review
HTLF Bank reduced its Bristol-Myers Squibb (BMY) stake by 7.4% in Q4 2024, selling an estimated $26.4K and leaving 5,933 shares worth $336K. The position accounts for 0.04% of the portfolio, ranked #158.
HTLF Bank first reported a position in BMY in Q4 2023 and has held it in 5 quarters since. The position peaked at $368K in Q4 2023. 2,486 funds tracked by Wall St. Rank hold BMY as of Q4 2024.
- HTLF Bank held 5,933 shares of Bristol-Myers Squibb worth $336K as of Q4 2024.
- HTLF Bank sold 472 Bristol-Myers Squibb shares in Q4 2024, an estimated $26.4K.
- Bristol-Myers Squibb made up 0.04% of HTLF Bank's portfolio in Q4 2024, its #158 holding.
- HTLF Bank first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 5 quarters since.
- HTLF Bank's Bristol-Myers Squibb position peaked at $368K in Q4 2023.
- 2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.
Based on HTLF Bank's 13F filing for Q4 2024, filed 28 Jan 2025.